Clene (CLNN) Net Cash Flow (2020 - 2025)
Clene (CLNN) posted Net Cash Flow of -$2.8 million for Q4 2025, down 503.07% on a QoQ basis from $684000.0 in Q3 2025, and down 19.87% year-over-year from -$3.4 million in Q4 2024.
Analysis
Clene (CLNN) Net Cash Flow (2020 - 2025) Analysis & Trends
Clene has reported Net Cash Flow for 6 years, with the latest figure at -$2.8 million in Q4 2025.
- On a quarterly basis, Net Cash Flow fell 19.87% year-over-year to -$2.8 million in Q4 2025; TTM through Dec 2025 was -$7.1 million, a 57.27% increase from a year earlier, with the FY2025 full-year figure at -$7.1 million, up 57.27% from the prior year.
- Net Cash Flow was -$2.8 million for Q4 2025 at Clene, down from $684000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $30.8 million in Q2 2023, with the low at -$37.4 million in Q1 2022.
- Average Net Cash Flow over 5 years is -$2.7 million, with a median of -$2.5 million recorded in 2025.
- The sharpest annual moves came in 2021 and 2023: Net Cash Flow surged 7594.53% in 2021, then slumped 41547.06% in 2023.
- Over 5 years, Net Cash Flow stood at -$10.3 million in 2021, then soared by 206.31% to $10.9 million in 2022, then slumped by 222.7% to -$13.4 million in 2023, then surged by 82.87% to -$2.3 million in 2024, then declined by 19.87% to -$2.8 million in 2025.
- The last three Net Cash Flow figures came in at -$2.8 million (Q4 2025), $684000.0 (Q3 2025), and -$2.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 918.27 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 374.50 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 521.33 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 523.50 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | 684,000.00 |
| Jun 30, 2025 | -2.66 Mn |
| Mar 31, 2025 | -2.34 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | -7.13 Mn |
| Jun 30, 2024 | -62,000.00 |
| Mar 31, 2024 | -7.05 Mn |
| Dec 31, 2023 | -13.43 Mn |
| Sep 30, 2023 | -7.05 Mn |
| Jun 30, 2023 | 30.85 Mn |
| Mar 31, 2023 | 92,000.00 |
| Dec 31, 2022 | 10.95 Mn |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | -5.50 Mn |
| Mar 31, 2022 | -37.39 Mn |
| Dec 31, 2021 | -10.30 Mn |
| Sep 30, 2021 | -2.31 Mn |
| Jun 30, 2021 | 15.06 Mn |
| Mar 31, 2021 | -11.30 Mn |